Juan Carlos
Montero González
Investigador desde 2021
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (3)
2021
-
Preclinical and clinical characterization of fibroblast-derived neuregulin-1 on trastuzumab and pertuzumab activity in HER2-positive breast cancer
Clinical Cancer Research, Vol. 27, Núm. 18, pp. 5096-5108
2014
-
Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling
BMC Cancer, Vol. 14, Núm. 1
2005
-
N-terminal cleavage of proTGFα occurs at the cell surface by a TACE-independent activity
Biochemical Journal, Vol. 389, Núm. 1, pp. 161-172